Compound based on benzimidazole-1-yl methanol core as well as preparation method and application of compound

Through compounds based on benzimidazole-1-ylmethanol core, the problem of prone to cracks and peeling of metal anticorrosion coatings is solved, and the metal anticorrosion effect in alkaline environment is achieved, the pH value is stable, the service life is extended, and through Structural modifications meet different application needs.

CN119060044AActive Publication Date: 2024-12-03SHANGHAI KESI MICRO SEMICONDUCTOR MATERIALS CO LTD

Patent Information

Application Number
CN202411127051.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-15
Publication Date
2024-12-03
Estimated Expiration
2044-08-15

AI Technical Summary

Technical Problem

Existing metal anti-corrosion coatings are prone to cracks and peeling, and have poor anti-corrosion effect, especially in alkaline environments, it is difficult to effectively prevent metal corrosion, and changes in pH value affect their service life.

Method used

The compounds based on the benzimidazole-1-ylmethanol core are prepared by reacting with 1-chloromethyl-1H-benzimidazole and base to form compounds of formula I or formula II for corrosion-proof applications on metal surfaces, and Keep the pH stable under alkaline environment.

Benefits of technology

Effectively prevent metals from corroding in alkaline environments, extend the service life of preservatives, and obtain compounds with different anticorrosion properties through structural modification, meeting various application needs.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119060044A_ABST
    Figure CN119060044A_ABST
Patent Text Reader

Abstract

The invention relates to a compound based on a benzimidazole-1-yl methanol core as well as a preparation method and application of the compound. The compound disclosed by the invention has a structure as shown in a formula I or a formula II: # imgabs0 #, wherein in the formula I, R is selected from 2-mercaptobenzothiazolyl, N-hydroxysuccinimido, N-(t-butyloxycarboryl) p-toluene sulfonamide or tetrahydro-2H-pyran-2-hydroxyl, and R is selected from 2-mercaptobenzothiazolyl, N-hydroxysuccinimido, N-(t-butyloxycarboryl) p-toluene sulfonamide or tetrahydro-2H-pyran-2-hydroxyl; x is selected from O, S or N; in the formula II, R'is selected from at least one of thiophene sulfuryl, 2-sulfoxide benzothiazolyl, 4-nitrophthalimide and the like. The compound disclosed by the invention can prevent metal from being corroded in an alkaline environment, and the pH value of a test solution is not obviously reduced. Meanwhile, proper chemical reagents and chemicals can be selected to carry out structural modification on a compound taking benzimidazole-1-yl methanol as an inner core, so that compounds with different corrosion resistance can be obtained, and different application requirements can be met.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of metal corrosion protection, and specifically relates to a compound based on an imidazole-1-ylmethanol core, and a preparation method and application thereof. Background Art

[0002] Metal corrosion is a phenomenon in which metals are destroyed by chemical or electrochemical effects of the environment. Metal corrosion affects all areas of marginal industrial production, causing huge economic losses, leading to an increase in the use of metal materials, and is not conducive to energy conservation, emission reduction and environmental protection.

[0003] Metal corrosion mainly includes two forms: electrochemical corrosion and seawater corrosion. Electrochemical corrosion is the damage caused by electrochemical reaction between the metal surface and the ion-conductive medium. Its main feature is that its reaction process can be divided into two relatively independent and simultaneous processes-cathode reaction and anode reaction. Its main feature is that there is a charged interface layer between the metal and the electrolyte. Seawater corrosion refers to the corrosion of equipment and facilities used in the marine environment. Seawater has the highest salt content and complex composition, and is a corrosive electrolyte. The high concentration of chloride ions and other halogen ions in seawater can prevent and destroy the passivation of metals, making the anode process easier to carry out. Under the pH value of seawater, seawater corrosion is an oxygen depolarization process, and the cathode process controls the speed of the corrosion reaction.

[0004] For a long time, people have been using a variety of technologies to protect metals. One of the most effective and economical methods is to apply an anti-corrosion coating on the metal surface to isolate the corrosive medium from the metal substrate. However, during the use of the coating, microcracks will occur due to changes in factors such as the environment or mechanical properties, and due to exposure to the atmosphere, the microcracks will gradually spread and expand, thereby accelerating the peeling and stratification of the coating at the interface between the metal and the coating, reducing the service life and anti-corrosion ability of the coating, and also affecting the use of the metal. Therefore, a metal preservative is needed to prevent the corrosion of metal materials and solve the problems of metal anti-corrosion coatings in the prior art that are prone to cracking, peeling, and poor anti-corrosion effects. Summary of the invention

[0005] In order to improve the above technical problems, the present invention provides a compound based on a benzimidazole-1-ylmethanol core and a preparation method and application thereof. The compound of the present invention can prevent metal corrosion in an alkaline environment and the pH value of the test liquid does not decrease significantly.

[0006] In order to achieve the above object, the present invention provides a compound with a structure shown in Formula I or Formula II:

[0007]

[0008] In Formula I, R is selected from 2-mercaptobenzothiazolyl, N-hydroxysuccinimide, N-(tert-butyloxycarbonyl)-p-toluenesulfonamide or tetrahydro-2H-pyran-2-hydroxy; X is selected from O, S or N;

[0009] In formula II, R' is selected from at least one of thiophenesulfone, 2-sulfoxidebenzothiazolyl and 4-nitrophthalimide.

[0010] According to an embodiment of the present invention, the compound represented by the structure of Formula I or Formula II is selected from the following compounds:

[0011]

[0012]

[0013] The present invention also provides a method for preparing the compound of the structure shown in the above formula I or formula II, its stereoisomers or pharmaceutically acceptable salts and hydrates thereof, comprising reacting 1-chloromethyl-1H-benzimidazole with a compound RX to obtain a compound of formula I or formula II; wherein: R and X have the definitions and selections as described above.

[0014] According to an embodiment of the present invention, the molar ratio of the 1-chloromethyl-1H-benzimidazole to the compound RX is 1:(1-5), exemplified by 1:1, 1:2, and 1:5.

[0015] According to an embodiment of the present invention, in the reaction of 1-chloromethyl-1H-benzimidazole with compound RX, a base is preferably added.

[0016] Preferably, the molar ratio of the 1-chloromethyl-1H-benzimidazole to the base is 1:(1-5), exemplified by 1:1, 1:2.2, and 1:5.

[0017] Preferably, the base is selected from one, two or more of N,N-diisopropylethylamine (DIPEA), potassium carbonate, sodium tert-butoxide, potassium tert-butoxide, potassium phosphate and sodium acetate.

[0018] According to an embodiment of the present invention, NaI is preferably added in the reaction between 1-chloromethyl-1H-benzimidazole and compound RX.

[0019] Preferably, the molar ratio of the 1-chloromethyl-1H-benzimidazole to NaI is 1:(1-5), exemplified by 1:1, 1:2, and 1:5.

[0020] According to an embodiment of the present invention, the method for preparing the compound of the structure represented by Formula I or Formula II can be carried out in the presence of a solvent such as an organic solvent. For example, the organic solvent can be selected from 1,2-dichloroethane and tetrahydrofuran.

[0021] According to an embodiment of the present invention, the reaction temperature is 40-100°C, exemplified by 40°C, 60°C, 80°C, and 100°C; the reaction time is 1-48h, exemplified by 1h, 2h, 4h, 6h, 8h, 12h, 16h, 24h, 36h, and 48h.

[0022] According to an embodiment of the present invention, the preparation method further comprises a step of separating a solid product from the reaction mixture after the reaction is completed. For example, a solid product is obtained by spin drying the solvent. Further, the preparation method further comprises a step of purifying the product. For example, the purification can be separated by column chromatography. Preferably, the eluent separated by the column chromatography is petroleum ether / ethyl acetate = (1 to 5): 1 (v / v), exemplified by 1: 1, 2: 1, 5: 1.

[0023] Preferably, the synthetic route of the compound of formula I or formula II is as follows:

[0024]

[0025] According to an embodiment of the present invention, the method for preparing the compound having a structure as shown in Formula I or Formula II comprises the following steps:

[0026] (1) Under nitrogen protection, a nucleophilic reagent RX, 1-chloromethyl-1H-benzimidazole, sodium iodide, a base and a solvent are stirred for reaction;

[0027] (2) After the reaction is completed, cool to room temperature and concentrate to remove the solvent;

[0028] (3) The crude product is purified by silica gel column chromatography using a mixed solvent of petroleum ether and ethyl acetate as an eluent to obtain a compound of formula I or formula II.

[0029] According to an embodiment of the present invention, the 1-chloromethyl-1H-benzimidazole is prepared by a nucleophilic substitution reaction between 1-hydroxymethyl-1H-benzimidazole and a chlorinating agent.

[0030] In one embodiment of the present invention, the molar ratio of 1-hydroxymethyl-1H-benzimidazole to the chlorinating agent is 1:(1-10), exemplified by 1:1, 1:6, and 1:10.

[0031] In one embodiment of the present invention, the chlorinating agent is, for example, selected from thionyl chloride, phosphorus trichloride or phosphorus oxychloride.

[0032] In one embodiment of the present invention, the preparation method of 1-chloromethyl-1H-benzimidazole can be carried out in the presence of a solvent such as an organic solvent. For example, the organic solvent can be selected from chloroform.

[0033] According to an embodiment of the present invention, the reaction temperature is room temperature; the reaction time is 1 to 48 hours, exemplified by 1 hour, 2 hours, 4 hours, 6 hours, 8 hours, 12 hours, 16 hours, 24 hours, 36 hours, and 48 hours.

[0034] According to an embodiment of the present invention, the preparation method further comprises the step of separating a solid product from the reaction mixture after the reaction is completed. For example, the solid product is obtained by spin drying the solvent.

[0035] According to an embodiment of the present invention, the 1-hydroxymethyl-1H-benzimidazole is prepared by reacting benzimidazole with formaldehyde.

[0036] In one embodiment of the present invention, the molar ratio of benzimidazole to formaldehyde is 1:(0.5-2), exemplified by 1:0.5, 1:1, 1:2.

[0037] In one embodiment of the present invention, the preparation method of 1-hydroxymethyl-1H-benzimidazole can be carried out in the presence of a solvent such as an organic solvent. For example, the organic solvent can be selected from tetrahydrofuran.

[0038] In one embodiment of the present invention, the reaction temperature is room temperature; the reaction time is 1 to 48 hours, exemplified by 1 hour, 2 hours, 4 hours, 6 hours, 8 hours, 12 hours, 16 hours, 24 hours, 36 hours, and 48 hours.

[0039] In one embodiment of the present invention, the preparation method further comprises a step of separating a solid product from the reaction mixture after the reaction is completed. For example, the solid product is obtained by spin-drying the solvent. Further, the preparation method further comprises a step of purifying the product. For example, the purification can be performed by recrystallization. Preferably, the solvent for the recrystallization can be ethanol and water.

[0040] In one embodiment of the present invention, the synthetic route of 1-chloromethyl-1H-benzimidazole is as follows:

[0041]

[0042] The present invention also provides the use of the compound represented by the structure of Formula I or Formula II in the cleaning and corrosion protection of the surface of metal products.

[0043] The present invention also provides a detergent containing the compound with the structure shown in the above formula I or formula II.

[0044] The present invention also provides a preservative, which contains the compound with the structure shown in the above formula I or formula II.

[0045] According to an embodiment of the present invention, the preservative further comprises an auxiliary agent. Preferably, the auxiliary agent is selected from a sustained-release agent and / or a surfactant.

[0046] In one embodiment of the present invention, the sustained release agent is selected from triethanolamine borate.

[0047] In one embodiment of the present invention, the surfactant is 2-amino-2-methyl-propanol.

[0048] According to an embodiment of the present invention, the preservative further contains tetramethylammonium hydroxide.

[0049] According to an embodiment of the present invention, in the preservative, the mass of the compound of the structure shown in Formula I or Formula II is 0.01% to 20% of the mass of tetramethylammonium hydroxide, and exemplified are 0.01%, 0.04%, 0.1%, 0.5%, 1%, 2%, 5%, 10%, 15%, and 20%.

[0050] The present invention also provides an anti-corrosion coating, which contains the compound with the structure shown in the above formula I or formula II and / or is prepared from the compound with the structure shown in the above formula I or formula II.

[0051] Beneficial effects of the present invention:

[0052] The present invention discloses a compound based on a benzimidazole-1-ylmethanol core, a preparation method and an application thereof. The compound of the present invention can prevent metal from being corroded in an alkaline environment and the pH value of the test liquid does not decrease significantly. At the same time, the present invention can select suitable chemical reagents and chemicals to modify the structure of the compound based on "benzimidazole-1-ylmethanol" as the core to obtain compounds with different anticorrosion properties to meet different application requirements. BRIEF DESCRIPTION OF THE DRAWINGS

[0053] Figure 1 The 2-(((1H-benzo[d]imidazol-1-yl)methyl)thio)benzo[d]thiazole compound prepared in Example 1 1 H NMR spectrum.

[0054] Figure 2 The 2-(((1H-benzo[d]imidazol-1-yl)methyl)thio)benzo[d]thiazole compound prepared in Example 1 13 C NMR spectrum.

[0055] Figure 3 This is the HRMS spectrum of the 2-(((1H-benzo[d]imidazol-1-yl)methyl)thio)benzo[d]thiazole compound prepared in Example 1.

[0056] Figure 4The 1-((1H-benzimidazol-1-yl)methoxy)pyrrolidine-2,5-dione compound prepared in Example 2 1 H NMR spectrum.

[0057] Figure 5 The 1-((1H-benzimidazol-1-yl)methoxy)pyrrolidine-2,5-dione compound prepared in Example 2 13 C NMR spectrum.

[0058] Figure 6 This is the HRMS spectrum of the 1-((1H-benzimidazol-1-yl)methoxy)pyrrolidine-2,5-dione compound prepared in Example 2.

[0059] Figure 7 The 2-((1H-benzimidazol-1-yl)methyl)-5-nitroisoindoline-1,3-dione compound prepared in Example 3 1 H NMR spectrum.

[0060] Figure 8 The 2-((1H-benzimidazol-1-yl)methyl)-5-nitroisoindoline-1,3-dione compound prepared in Example 3 13 C NMR spectrum.

[0061] Fig. 9 This is the HRMS spectrum of the 2-((1H-benzimidazol-1-yl)methyl)-5-nitroisoindoline-1,3-dione compound prepared in Example 3.

[0062] Fig.10 The tert-butyl ((1H-benzimidazol-1-yl)methyl)(toluenesulfonyl)carbamate compound prepared in Example 4 1 H NMR spectrum.

[0063] Fig.11 The tert-butyl ((1H-benzimidazol-1-yl)methyl)(toluenesulfonyl)carbamate compound prepared in Example 4 13 C NMR spectrum.

[0064] Fig.12 This is the HRMS spectrum of the ((1H-benzimidazol-1-yl)methyl)(tosyl)carbamic acid tert-butyl ester compound prepared in Example 4.

[0065] Fig.13 The 1-(((tetrahydro-2H-pyran-2-yl)oxy)methyl)-1H-benzimidazole compound prepared in Example 5 1 H NMR spectrum.

[0066] Fig.14 The 1-(((tetrahydro-2H-pyran-2-yl)oxy)methyl)-1H-benzimidazole compound prepared in Example 5 13 C NMR spectrum. DETAILED DESCRIPTION

[0067] The technical scheme of the present invention will be further described in detail below in conjunction with specific embodiments. It should be understood that the following embodiments are only exemplary descriptions and explanations of the present invention and should not be construed as limiting the scope of protection of the present invention. All technologies implemented based on the above content of the present invention are included in the scope that the present invention is intended to protect.

[0068] Unless otherwise specified, the raw materials and reagents used in the following examples are commercially available or can be prepared by known methods.

[0069] In the following embodiments of the present invention, the preparation method of 1-chloromethyl-1H-benzimidazole has the following reaction equation:

[0070]

[0071] The preparation method of 1-chloromethyl-1H-benzimidazole comprises the following steps:

[0072] (1) Benzimidazole (10.0 g, 84.65 mmol) and tetrahydrofuran (250.0 mL) were added to a 250.0 mL reaction flask in sequence, followed by dropwise addition of formaldehyde aqueous solution (37% in H 2 O, 6.8g, 84.65mmol), stirred at room temperature for 12h;

[0073] (2) After stirring for 12 h, the components were concentrated on a rotary evaporator without any post-treatment;

[0074] (3) The crude product was recrystallized with ethanol and water, and filtered to obtain a white solid (yield: 64%), namely 1-hydroxymethyl-1H-benzimidazole, with the structural formula:

[0075] (4) 1-Hydroxymethyl-1H-benzimidazole (1.5 g, 10.0 mmol) and chloroform (50.0 mL) were added sequentially to a 250.0 mL reaction bottle, followed by dropwise addition of thionyl chloride (7.1 g, 60.0 mmol), and the reaction was stirred at room temperature for 6 h;

[0076] (5) After stirring for 6 h, the components were concentrated on a rotary evaporator without any post-treatment to directly obtain the desired white solid (yield 89%), namely 1-chloromethyl-1H-benzimidazole, with the structural formula:

[0077]

[0078] Example 1

[0079] This embodiment provides a method for preparing 2-(((1H-benzo[d]imidazol-1-yl)methyl)thio)benzo[d]thiazole, and the reaction equation is as follows:

[0080]

[0081] A method for preparing 2-(((1H-benzo[d]imidazol-1-yl)methyl)thio)benzo[d]thiazole comprises the following steps:

[0082] (1) Under nitrogen protection, 2-mercaptobenzothiazole (1.67 g, 10.0 mmol), 1-chloromethyl-1H-benzimidazole (2.2 g, 11.0 mmol), sodium iodide (1.5 g, 10.0 mmol) and potassium carbonate (3.0 g, 22.0 mmol) and 1,2-dichloroethane (50.0 mL) were added to a 250.0 mL reaction bottle in sequence, and the mixture was stirred at 60°C for 16 h.

[0083] (2) After stirring for 16 h, the mixture was cooled to room temperature and concentrated on a rotary evaporator at 40 °C without any post-treatment;

[0084] (3) The crude product was purified by silica gel column chromatography using a mixed solvent of petroleum ether and ethyl acetate in a volume ratio of 2:1 as the eluent to obtain a white solid (yield: 60%), namely 2-(((1H-benzo[d]imidazol-1-yl)methyl)thio)benzo[d]thiazole, having the structural formula:

[0085] The basic parameters of the 2-(((1H-benzo[d]imidazol-1-yl)methyl)thio)benzo[d]thiazole compound prepared in this example are as follows:

[0086] 1 H NMR (400 MHz, CDCl 3 )δ8.29(s,1H),7.98(d,J=8.1Hz,1H),7.79(m,1H),7.73(d,J=9.2Hz,1H),7.54-7.43(m,2H),7.37-7.28(m,3H),6.10(s,2H)( Figure 1 );

[0087] 13 C NMR (101 MHz, CDCl 3)δ163.1,152.6,144.1,143.1,135.6,133.0,126.5,125.0,123.5,122.9,122.0,121.3,120.8,110.0,45.8( Figure 2 );

[0088] HRMS (ESI) m / z measured the 2-(((1H-benzo[d]imidazol-1-yl)methyl)thio)benzo[d]thiazole C prepared in this example 15 H 11 N 3 S 2 Molecular weight [M+H] + is 298.0467, and its theoretical molecular weight is 298.0463 ( Figure 3 ).

[0089] Example 2

[0090] This embodiment provides a method for preparing 1-((1H-benzimidazol-1-yl)methoxy)pyrrolidine-2,5-dione, and the reaction equation is:

[0091]

[0092] A method for preparing 1-((1H-benzimidazol-1-yl)methoxy)pyrrolidine-2,5-dione comprises the following steps:

[0093] (1) Under nitrogen protection, N-hydroxysuccinimide (1.16 g, 10.0 mmol), 1-chloromethyl-1H-benzimidazole (2.2 g, 11.0 mmol), sodium iodide (1.5 g, 10.0 mmol) and N,N-diisopropylethylamine (DIPEA, 2.8 g, 22.0 mmol) and 1,2-dichloroethane (50.0 mL) were added to a 250.0 mL reaction bottle in sequence, and the mixture was stirred at 60°C for 16 h.

[0094] (2) After stirring for 16 h, the mixture was cooled to room temperature and the components were concentrated on a rotary evaporator without any post-treatment;

[0095] (3) The crude product was purified by silica gel column chromatography using a mixed solvent of ethyl acetate and methanol in a volume ratio of 100:1 as the eluent to obtain a white solid (yield: 60%), namely 1-((1H-benzimidazol-1-yl)methoxy)pyrrolidine-2,5-dione, with the structural formula:

[0096] The basic parameters of the 1-((1H-benzimidazol-1-yl)methoxy)pyrrolidine-2,5-dione compound prepared in this example are as follows:

[0097] 1 H NMR (400 MHz, DMSO-d 6 )δ8.40(s,1H),7.70(dd,J=17.6,7.9Hz,2H),7.41-7.22(m,2H),6.11(s,2H),2.57(s,4H)( Figure 4 );

[0098] 13 C NMR (101 MHz, DMSO-d 6 )δ171.6,144.8,143.5,133.7,123.2,122.5,119.6,110.5,77.2,25.4( Figure 5 );

[0099] HRMS (ESI) m / z measured the 1-((1H-benzimidazol-1-yl)methoxy)pyrrolidine-2,5-dione C prepared in this example 12 H 11 N 3 O 3 Molecular weight [M+H] + is 246.0873, and its theoretical molecular weight is 246.0870 ( Figure 6 ).

[0100] Example 3

[0101] This embodiment provides a method for preparing 2-((1H-benzimidazol-1-yl)methyl)-5-nitroisoindoline-1,3-dione, and the reaction equation is:

[0102]

[0103] A method for preparing 2-((1H-benzimidazol-1-yl)methyl)-5-nitroisoindoline-1,3-dione comprises the following steps:

[0104] (1) Under nitrogen protection, 4-nitrophthalimide (3.4 g, 10.0 mmol), 1-chloromethyl-1H-benzimidazole (2.2 g, 11.0 mmol), sodium iodide (1.5 g, 10.0 mmol) and N,N-diisopropylethylamine (DIPEA, 2.8 g, 22.0 mmol) and 1,2-dichloroethane (50.0 mL) were added to a 250.0 mL reaction bottle in sequence, and the mixture was stirred at 60°C for 16 h.

[0105] (2) After stirring for 16 h, the mixture was cooled to room temperature and the components were concentrated on a rotary evaporator without any post-treatment;

[0106] (3) The crude product was purified by silica gel column chromatography using a mixed solvent of petroleum ether and ethyl acetate in a volume ratio of 1:1 as the eluent to obtain a yellow solid (yield: 60%), namely 2-((1H-benzimidazol-1-yl)methyl)-5-nitroisoindoline-1,3-dione, with the structural formula:

[0107] When potassium carbonate and potassium tert-butoxide were used instead of DIPEA, no 2-((1H-benzimidazol-1-yl)methyl)-5-nitroisoindoline-1,3-dione product was generated.

[0108] The basic parameters of the 2-((1H-benzimidazol-1-yl)methyl)-5-nitroisoindoline-1,3-dione compound prepared in this example are as follows:

[0109] 1 H NMR (400 MHz, CDCl 3 )δ8.61(d,J=1.9Hz,1H),8.56(dd,J=8.1,2.0Hz,1H),8.21(s,1H),8.05(d,J=8.2Hz ,1H),7.74(d,J=8.0Hz,1H),7.68(d,J=7.9Hz,1H),7.34-7.19(m,2H),6.00(s,2H)( Figure 7 );

[0110] 13 C NMR (101 MHz, CDCl 3 )δ165.3,165.0,152.0,143.9,143.4,135.8,132.8,132.7,129.9,125.3,123.9,123.0,120.4,119.3,110.2,45.6( Figure 8 );

[0111] HRMS (ESI) m / z measured the 2-((1H-benzimidazol-1-yl)methyl)-5-nitroisoindoline-1,3-dione C prepared in this example 16 H 10 N 4 O 4 Molecular weight [M+H] + is 323.0775, and its theoretical molecular weight is 323.0771 ( Fig. 9 ).

[0112] Example 4

[0113] This embodiment provides a method for preparing tert-butyl ((1H-benzimidazol-1-yl)methyl)(toluenesulfonyl)carbamate, and the reaction equation is:

[0114]

[0115] A method for preparing tert-butyl ((1H-benzimidazol-1-yl)methyl)(tosyl)carbamate comprises the following steps:

[0116] (1) Under nitrogen protection, N-(tert-butyloxycarbonyl)-p-toluenesulfonamide (2.7 g, 10.0 mmol), 1-chloromethyl-1H-benzimidazole (2.2 g, 11.0 mmol), sodium iodide (1.5 g, 10.0 mmol) and potassium carbonate (3.0 g, 22.0 mmol) and tetrahydrofuran (50.0 mL) were added to a 250.0 mL reaction bottle in sequence, and the mixture was stirred at 60°C for 14 h.

[0117] (2) After stirring for 14 h, the mixture was cooled to room temperature and the components were concentrated on a rotary evaporator without any post-treatment;

[0118] (3) The crude product was purified by silica gel column chromatography using a mixed solvent of petroleum ether and ethyl acetate in a volume ratio of 1:3 as the eluent to obtain a white solid (yield: 63%), i.e., tert-butyl ((1H-benzimidazol-1-yl)methyl)(tosyl)carbamate, having the structural formula:

[0119] The basic parameters of the ((1H-benzimidazol-1-yl)methyl)(tosyl)carbamic acid tert-butyl ester compound prepared in this example are as follows:

[0120] 1 H NMR (400 MHz, CDCl 3 )δ8.25(s,1H),7.83-7.72(m,2H),7.31-7.21(m,5H),7.04(d,J=10.2Hz,2H),6.19(s,2H),2.28(s,3H),1.29(s,9H)( Fig.10 );

[0121] 13 C NMR (101 MHz, CDCl 3 )δ150.5,144.7,144.4,143.2,136.0,133.0,129.2,127.4,123.5,122.6,120.1,110.9,86.1,53.1,27.6,21.4( Fig.11 );

[0122] HRMS (ESI) m / z measured the ((1H-benzimidazol-1-yl)methyl)(toluenesulfonyl)carbamic acid tert-butyl ester compound C prepared in this example 20 H 23 N 3 O 4 Molecular weight of S [M+H] + is 402.14820, and its theoretical molecular weight is 402.14763 ( Fig.12 ).

[0123] The method is basically the same as the above preparation method, except that the base potassium carbonate is replaced by tBuOK and DIPEA in sequence. The experimental results show that:

[0124] When tBuOK was used as the base, the yield of tert-butyl ((1H-benzimidazol-1-yl)methyl)(tosyl)carbamate was 26%.

[0125] When DIPEA was used as the base, the yield of tert-butyl ((1H-benzimidazol-1-yl)methyl)(tosyl)carbamate was 78%.

[0126] Example 5

[0127] This embodiment provides a method for preparing 1-(((tetrahydro-2H-pyran-2-yl)oxy)methyl)-1H-benzimidazole, and the reaction equation is:

[0128]

[0129] The preparation method of 1-(((tetrahydro-2H-pyran-2-yl)oxy)methyl)-1H-benzimidazole comprises the following steps:

[0130] (1) Under nitrogen protection, 1-chloromethyl-1H-benzimidazole (1.1 g, 5.5 mmol), sodium iodide (0.75 g, 5.0 mmol), potassium tert-butoxide (1.2 g, 11.0 mmol), tetrahydrofuran (20.0 mL) solvent, and tetrahydro-2H-pyran-2-ol (0.51 g, 5.0 mmol) were added to a 250.0 mL reaction bottle in sequence, and the mixture was stirred at 60°C for 16 h.

[0131] (2) After stirring for 16 h, the mixture was cooled to room temperature and concentrated on a rotary evaporator at 40 °C without any post-treatment;

[0132] (3) The crude product was purified by silica gel column chromatography using a mixed solvent of petroleum ether and ethyl acetate in a volume ratio of 1:2 as the eluent to obtain a colorless oil (yield: 31%), namely 1-(((tetrahydro-2H-pyran-2-yl)oxy)methyl)-1H-benzimidazole, with the structural formula:

[0133] The basic parameters of the 1-(((tetrahydro-2H-pyran-2-yl)oxy)methyl)-1H-benzimidazole compound prepared in this example are as follows:

[0134] 1 H NMR (400 MHz, CDCl 3 )δ8.05(s,1H),7.80(d,J=7.1Hz,1H),7.56(d,J=6.6Hz,1H),7.39-7.27(m,2H),5.74(d,J=11.4Hz,1H),5.60 (d,J=11.5Hz,1H),4.62(s,1H),3.80-3.67(m,1H),3.62–3.28(m,1H),1.83-1.71(m,1H),1.71-1.41(m,5H)( Fig.13 );

[0135] 13 C NMR (101 MHz, CDCl 3 )δ143.54,143.50,133.8,123.7,122.9,120.3,110.3,95.4,69.8,62.4,29.8,25.2,18.8( Fig.14 ).

[0136] Test Example 1

[0137] Add 10.0g of DEV base (2.38% tetramethylammonium hydroxide aqueous solution) to a 20.0mL conical flask, add a magnet, turn on electromagnetic stirring to mix the solution evenly, and set the water bath temperature to 25-27°C. Then cut the aluminum sheet into 1cm*1cm small squares and put them in the conical flask. After soaking for 1 hour, take it out with tweezers, rinse both sides with distilled water several times, wipe dry and weigh it. Then put it in the solution again, soak for another 2 hours (3 hours in total), weigh the weight after corrosion, and then measure the pH value of the solution at 18°C. The measurement results are shown in Table 1 below.

[0138] Table 1

[0139]

[0140] Test Example 2

[0141] Add 10.0g of DEV base (aqueous solution of tetramethylammonium hydroxide with a concentration of 2.38%), 0.2g of additive 1 (triethanolamine borate sustained-release agent), and 0.01g of additive 2 (2-amino-2-methyl-propanol surfactant) to a 20.0mL conical flask, add a magnet, turn on electromagnetic stirring, mix the solution evenly, and set the water bath temperature to 25-27°C. Then cut the aluminum sheet into 1cm*1cm small squares and put them in the conical flask. After soaking for 1 hour, take it out with tweezers, rinse both sides with distilled water several times, wipe dry and weigh it. Then put it in the solution again, soak for another 2 hours (a total of 3 hours), weigh the weight after corrosion, and then measure the pH value of the solution at 18°C. The measurement results are shown in Table 2 below.

[0142] Table 2

[0143]

[0144] Test Example 3

[0145] In a 20.0mL conical flask, add 25.0g of DEV base (aqueous solution of tetramethylammonium hydroxide with a concentration of 2.38%), 0.15g of additive 1 (triethanolamine borate sustained-release agent), 0.01g of additive 2 (2-amino-2-methyl-propanol surfactant), 0.2g of 2-(((1H-benzo[d]imidazol-1-yl)methyl)thio)benzo[d]thiazole complexing agent prepared in Example 1 (insoluble, dispersed in the system), add a magnet, turn on electromagnetic stirring, mix the solution evenly, and set the water bath temperature to 25-27°C. Then cut the aluminum sheet into 1cm*1cm small squares and put them in the conical flask. After soaking for 1 hour, take it out with tweezers, rinse both sides with distilled water several times, wipe dry and weigh it. Then put it in the solution again, soak for another 2 hours (a total of 3 hours), weigh the weight after corrosion, and then measure the pH value of the solution at 18°C. The measurement results are shown in Table 3 below.

[0146] Table 3

[0147]

[0148] Test Example 4

[0149] In a 20.0mL conical flask, add 25.0g of DEV base (aqueous solution of tetramethylammonium hydroxide with a concentration of 2.38%), 0.2g of additive 1 (triethanolamine borate sustained release agent), 0.01g of additive 2 (2-amino-2-methyl-propanol surfactant), 0.15g of 1-((1H-benzimidazole-1-yl)methoxy)pyrrolidine-2,5-dione complexing agent prepared in Example 2 (insoluble, dispersed in the system), add a magnetic particle, turn on electromagnetic stirring, mix the solution evenly, and set the water bath temperature to 25-27°C. Then cut the aluminum sheet into 1cm*1cm small squares and put them in the conical flask. After soaking for 1 hour, take it out with tweezers, rinse both sides with distilled water several times, wipe dry and weigh it. Then put it in the solution again, soak for another 2 hours (a total of 3 hours), weigh the weight after corrosion, and then measure the pH value of the solution at 18°C. The measurement results are shown in Table 4 below.

[0150] Table 4

[0151]

[0152] Test Example 5

[0153] In a 20.0mL conical flask, add 25.0g of DEV base (aqueous solution of tetramethylammonium hydroxide with a concentration of 2.38%), 0.15g of additive 1 (triethanolamine borate sustained-release agent), 0.01g of additive 2 (2-amino-2-methyl-propanol surfactant), 0.04g of ((1H-benzimidazole-1-yl)methyl)(toluenesulfonyl)carbamic acid tert-butyl ester complexing agent prepared in Example 4 (insoluble, dispersed in the system), add a magnetic particle, turn on electromagnetic stirring, mix the solution evenly, and set the water bath temperature to 25-27°C. Then cut the aluminum sheet into 1cm*1cm small squares and put them into the conical flask. After soaking for 1 hour, take it out with tweezers, rinse both sides with distilled water several times, wipe dry and weigh it. Then put it into the solution again, soak for another 2 hours (a total of 3 hours), weigh the weight after corrosion, and then measure the pH value of the solution at 18°C. The measurement results are shown in Table 5 below.

[0154] Table 5

[0155]

[0156] Test Example 6

[0157] In a 20.0mL conical flask, add 25.0g of DEV base (aqueous solution of tetramethylammonium hydroxide with a concentration of 2.38%), 0.15g of additive 1 (triethanolamine borate sustained-release agent), 0.01g of additive 2 (2-amino-2-methyl-propanol surfactant), 0.04g of 1-(((tetrahydro-2H-pyran-2-yl)oxy)methyl)-1H-benzimidazole complexing agent prepared in Example 5 (small oil droplets do not dissolve), add a magnetic particle, turn on electromagnetic stirring, mix the solution evenly, and set the water bath temperature to 25-27°C. Then cut the aluminum sheet into 1cm*1cm small squares and put them in the conical flask. After soaking for 1 hour, take it out with tweezers, rinse both sides with distilled water several times, wipe dry and weigh it. Then put it in the solution again, soak for another 2 hours (a total of 3 hours), weigh the weight after corrosion, and then measure the pH value of the solution at 18°C. The measurement results are shown in Table 6 below.

[0158] Table 6

[0159]

[0160] Test Example 7

[0161] In a 20.0mL conical flask, add 25.0g of DEV base (aqueous solution of tetramethylammonium hydroxide with a concentration of 2.38%), 0.2g of additive 1 (triethanolamine borate sustained-release agent), 0.01g of additive 2 (2-amino-2-methyl-propanol surfactant), 0.03g of 1-(((tetrahydro-2H-pyran-2-yl)oxy)methyl)-1H-benzimidazole complexing agent prepared in Example 5 (small oil droplets do not dissolve), add a magnet, turn on electromagnetic stirring, mix the solution evenly, and set the water bath temperature to 25-27°C. Then cut the aluminum sheet into 1cm*1cm small squares and put them in the conical flask. After soaking for 1 hour, take it out with tweezers, rinse both sides with distilled water several times, wipe dry and weigh it. Then put it in the solution again, soak for another 2 hours (a total of 3 hours), weigh the weight after corrosion, and then measure the pH value of the solution at 18°C. The measurement results are shown in Table 7 below.

[0162] Table 7

[0163]

[0164] Test Example 8

[0165] In a 20.0mL conical flask, add 10.0g of DEV base (aqueous solution of tetramethylammonium hydroxide with a concentration of 2.38%), 0.15g of additive 1 (triethanolamine borate sustained-release agent), 0.01g of additive 2 (2-amino-2-methyl-propanol surfactant), 0.2g (completely dissolved) of 1-((1H-benzimidazole-1-yl)methoxy)pyrrolidine-2,5-dione complexing agent prepared in Example 2, add a magnetic bar, turn on electromagnetic stirring, mix the solution evenly, and set the water bath temperature to 25-27°C. Then cut the aluminum sheet into 1cm*1cm small squares and put them in the conical flask. After soaking for 1 hour, take it out with tweezers, rinse both sides with distilled water several times, wipe dry and weigh it. Then put it in the solution again, soak for another 2 hours (a total of 3 hours), weigh the weight after corrosion, and then measure the pH value of the solution at 18°C. The measurement results are shown in Table 8 below.

[0166] Table 8

[0167]

[0168] Test Example 9

[0169] In a 20.0mL conical flask, add 10.0g of DEV base (aqueous solution of tetramethylammonium hydroxide with a concentration of 2.38%), 0.2g of additive 1 (triethanolamine borate sustained-release agent), 0.01g of additive 2 (2-amino-2-methyl-propanol surfactant), 0.15g (completely dissolved) of 1-((1H-benzimidazole-1-yl)methoxy)pyrrolidine-2,5-dione complexing agent prepared in Example 2, add a magnetic bar, turn on electromagnetic stirring, mix the solution evenly, and set the water bath temperature to 25-27°C. Then cut the aluminum sheet into 1cm*1cm small squares and put them in the conical flask. After soaking for 1 hour, take it out with tweezers, rinse both sides with distilled water several times, wipe dry and weigh it. Then put it in the solution again, soak for another 2 hours (a total of 3 hours), weigh the weight after corrosion, and then measure the pH value of the solution at 18°C. The measurement results are shown in Table 9 below.

[0170] Table 9

[0171]

[0172] Test Example 10

[0173] Take 10.0g of each of the reference solutions I, II, III, and IV in Table 10 and add them to four conical flasks respectively, then add 20.0mg of the 1-((1H-benzimidazole-1-yl)methoxy)pyrrolidine-2,5-dione complexing agent (completely dissolved) prepared in Example 2, and measure the pH value of the solution at 25-27°C after dissolution; then cut the aluminum sheet into 1cm*1cm small squares and put them into the conical flask. After soaking for 1 hour, take it out with tweezers, rinse both sides with distilled water several times, wipe dry and weigh; measure the pH value of the solution at 25-27°C. Then put it into the solution again, soak for another 2 hours (3 hours in total), weigh the weight after corrosion, and then measure the pH value of the solution at 25-27°C. The measurement results are shown in Tables 11 and 12 below.

[0174] Table 10

[0175] Reference fluid Ⅰ DEV base 50g Additive 1 0.75g Additive 2 0.05g Reference Fluid Ⅱ DEV base 50g Additive 1 1g Additive 2 0.05g Reference fluid Ⅲ DEV base 50g - Additive 2 0.05g Reference fluid IV DEV base 50g - -

[0176] Note: “-” in the table means no addition; DEV base is a 2.38% tetramethylammonium hydroxide aqueous solution, additive 1 is a triethanolamine borate sustained-release agent, and additive 2 is a 2-amino-2-methyl-propanol surfactant.

[0177] Table 11

[0178]

[0179] Note: Conditions Ⅰ, ⅠⅠ, ⅠⅠⅠ and ⅠV in the table correspond to the above-mentioned reference solution Ⅰ, reference solution ⅠⅠ and reference solution ⅠV respectively.

[0180] ⅠⅠⅠ, reference fluid IV.

[0181] Table 12

[0182]

[0183] Note: Conditions Ⅰ, ⅠⅠ, ⅠⅠⅠ and ⅠV in the table correspond to the above-mentioned reference solution Ⅰ, reference solution ⅠⅠ and reference solution ⅠV respectively.

[0184] ⅠⅠⅠ, reference fluid IV.

[0185] Test Example 11

[0186] In a 20.0mL conical flask, add 10.0g of DEV base (aqueous solution of tetramethylammonium hydroxide with a concentration of 2.38%), 0.15g of additive 1 (triethanolamine borate sustained-release agent), 0.01g of additive 2 (2-amino-2-methyl-propanol surfactant), 0.2g (completely dissolved) of the 2-((1H-benzimidazole-1-yl)methyl)-5-nitroisoindoline-1,3-dione complexing agent prepared in Example 3, add a magnetic bar, turn on electromagnetic stirring, mix the solution evenly, and set the water bath temperature to 25-27°C. Then cut the aluminum sheet into 1cm*1cm small squares and put them in the conical flask. After soaking for 1 hour, take it out with tweezers, rinse both sides with distilled water several times, wipe dry and weigh it. Then put it in the solution again, soak for another 2 hours (a total of 3 hours), weigh the weight after corrosion, and then measure the pH value of the solution at 18°C. The measurement results are shown in Table 13 below.

[0187] Table 13

[0188]

[0189] Test Example 12

[0190] In a 20.0mL conical flask, add 10.0g of DEV base (aqueous solution of tetramethylammonium hydroxide with a concentration of 2.38%), 0.2g of additive 1 (triethanolamine borate sustained-release agent), 0.01g of additive 2 (2-amino-2-methyl-propanol surfactant), 0.15g (completely dissolved) of 2-((1H-benzimidazole-1-yl)methyl)-5-nitroisoindoline-1,3-dione complexing agent prepared in Example 3, add a magnetic bar, turn on electromagnetic stirring, mix the solution evenly, and set the water bath temperature to 25-27°C. Then cut the aluminum sheet into 1cm*1cm small squares and put them in the conical flask. After soaking for 1 hour, take it out with tweezers, rinse both sides with distilled water several times, wipe dry and weigh it. Then put it in the solution again, soak for another 2 hours (3 hours in total), weigh the weight after corrosion, and then measure the pH value of the solution at 18°C. The measurement results are shown in Table 14 below.

[0191] Table 14

[0192]

[0193] Test Example 13

[0194] Take 10.0g of each of the reference solutions I, II, III, and IV in Table 10 above and add them to four conical flasks respectively, then add 20.0mg of the 2-((1H-benzimidazole-1-yl)methyl)-5-nitroisoindoline-1,3-dione complexing agent (completely dissolved) prepared in Example 3 to each, and measure the pH value of the solution at 25-27°C after dissolution; then cut the aluminum sheet into 1cm*1cm small squares and put them into the conical flask. After soaking for 1 hour, take it out with tweezers, rinse both sides with distilled water several times, wipe dry and weigh; measure the pH value of the solution at 25-27°C. Then put it into the solution again, soak for another 2 hours (3 hours in total), weigh the weight after corrosion, and then measure the pH value of the solution at 25-27°C. The measurement results are shown in Tables 15 and 16 below.

[0195] Table 15

[0196]

[0197] Note: Conditions Ⅰ, ⅠⅠ, ⅠⅠⅠ and ⅠV in the table correspond to the above-mentioned reference solution Ⅰ, reference solution ⅠⅠ and reference solution ⅠV respectively.

[0198] ⅠⅠⅠ, reference fluid IV.

[0199] Table 16

[0200]

[0201]

[0202] Note: Conditions Ⅰ, ⅠⅠ, ⅠⅠⅠ and ⅠV in the table correspond to the above-mentioned reference solution Ⅰ, reference solution ⅠⅠ and reference solution ⅠV respectively.

[0203] ⅠⅠⅠ, reference fluid IV.

[0204] The above is an explanation of the embodiments of the present invention. However, the present invention is not limited to the above embodiments. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall be included in the protection scope of the present invention.

Claims

1. A compound having a structure shown in Formula I or Formula II: In Formula I, R is selected from 2-mercaptobenzothiazolyl, N-hydroxysuccinimide, N-(tert-butyloxycarbonyl)-p-toluenesulfonamide or tetrahydro-2H-pyran-2-hydroxy; X is selected from O, S or N; In formula II, R' is selected from at least one of thiophenesulfone, 2-sulfoxidebenzothiazolyl and 4-nitrophthalimide.

2. The compound of formula I or formula II as claimed in claim 1, characterized in that: It is selected from the following compounds:

3. A method for preparing a compound of formula I or II, a stereoisomer thereof, or a pharmaceutically acceptable salt or hydrate thereof according to claim 1, characterized in that: The preparation method comprises reacting 1-chloromethyl-1H-benzimidazole with a compound RX to obtain a compound of formula I or formula II; wherein: R and X have the definitions and selections as described above.

4. The preparation method according to claim 3, characterized in that: The molar ratio of the 1-chloromethyl-1H-benzimidazole to the compound RX is 1:(1-5); Preferably, in the reaction of 1-chloromethyl-1H-benzimidazole and compound RX, a base is preferably added; Preferably, the molar ratio of 1-chloromethyl-1H-benzimidazole to the base is 1:(1-5); Preferably, the base is selected from one, two or more of N,N-diisopropylethylamine (DIPEA), potassium carbonate, sodium tert-butoxide, potassium tert-butoxide, potassium phosphate, and sodium acetate; Preferably, in the reaction of 1-chloromethyl-1H-benzimidazole and compound RX, NaI is preferably added; Preferably, the molar ratio of 1-chloromethyl-1H-benzimidazole to NaI is 1:(1-5); Preferably, the method for preparing the compound of the structure represented by Formula I or Formula II can be carried out in the presence of a solvent such as an organic solvent. For example, the organic solvent can be selected from 1,2-dichloroethane and tetrahydrofuran; Preferably, the reaction temperature is 40 to 100° C.; the reaction time is 1 to 48 hours; Preferably, the preparation method further comprises the step of separating a solid product from the reaction mixture after the reaction is completed, for example, by spin-drying the solvent to obtain a solid product; Preferably, the preparation method further comprises the step of purifying the product, for example, the purification can be carried out by column chromatography separation; preferably, the eluent for column chromatography separation is petroleum ether / ethyl acetate = (1-5): 1 (v / v).

5. The preparation method according to claim 3 or 4, characterized in that: The method for preparing the compound of the structure shown in Formula I or Formula II comprises the following steps: (1) Under nitrogen protection, a nucleophilic reagent RX, 1-chloromethyl-1H-benzimidazole, sodium iodide, a base and a solvent are stirred for reaction; (2) After the reaction is completed, cool to room temperature and concentrate to remove the solvent; (3) The crude product is purified by silica gel column chromatography using a mixed solvent of petroleum ether and ethyl acetate as an eluent to obtain a compound of formula I or formula II.

6. Use of the compound of formula I or II as claimed in claim 1 or 2 in cleaning and anti-corrosion of metal product surfaces.

7. A detergent, characterized in that It contains the compound with the structure shown by formula I or formula II as claimed in claim 1 or 2.

8. A preservative, characterized in that It contains the compound with the structure shown by formula I or formula II as claimed in claim 1 or 2.

9. The preservative according to claim 8, characterized in that The preservative also contains an auxiliary agent; Preferably, the auxiliary agent is selected from a sustained-release agent and / or a surfactant; Preferably, the sustained-release agent is selected from triethanolamine borate; Preferably, the surfactant is 2-amino-2-methyl-propanol; Preferably, the preservative further comprises tetramethylammonium hydroxide; Preferably, in the preservative, the mass of the compound with the structure represented by Formula I or Formula II is 0.01 to 20% of the mass of tetramethylammonium hydroxide.

10. An anti-corrosion coating, characterized in that: It contains the compound with the structure shown by formula I or formula II as claimed in claim 1 or 2 and / or is prepared from the compound with the structure shown by formula I or formula II as claimed in claim 1 or 2.

Citation Information

Patent Citations

  • Low dosage chemical suppression agents for carbon steels degradation

    US20180002821A1

  • Use of benzazoles as corrosion inhibitors

    US4235838A

Cited By

  • Preparation method and application of compound based on benzimidazole-1-yl methanol core

    CN119060043A

  • Preparation method and application of compounds based on benzimidazol-1-ylmethanol core

    CN119060043B